Dianthus Therapeutics, Inc. /DE/ (DNTH)
Pharmaceutical Preparations
Latest Price
$104.77
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
20.92
P/B Ratio
5.01
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 8.20M | $799.0M | 14.96% | +432.2K | 2026-06-30 |
| BlackRock, Inc. | 4.12M | $401.0M | 7.53% | +948.1K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 3.89M | $379.0M | 7.10% | +2.60M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.23M | $314.0M | 5.89% | +634.1K | 2026-06-30 |
| Fairmount Funds Management LLC | 2.54M | $247.0M | 4.63% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.51M | $245.0M | 4.59% | +1.37M | 2026-06-30 |
| STATE STREET CORP | 2.36M | $229.0M | 4.30% | +958.5K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.16M | $210.0M | 3.94% | +128.3K | 2026-06-30 |
| Avidity Partners Management LP | 2.10M | $205.0M | 3.84% | -- | 2026-06-30 |
| Octagon Capital Advisors LP | 1.84M | $179.0M | 3.36% | -105.0K | 2026-06-30 |